Trial Condition(s):
Erectile Dysfunction
LEVITRA® 20mg Special Drug Use Investigation (long-term)
Bayer Identifier:
13930
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction (ED) who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.
Inclusion Criteria
: - This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Many locations, Japan | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
LEVITRA® 20mg Special Drug Use Investigation (long-term)
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Efficacy of patients with LEVITRA treatmentTimeframe: After 6 months
Secondary Outcome
- LEVITRA treatment improved the patient's erectionTimeframe: After 6 months
- LEVITRA improved the patient's erection after Minimum and Maximum Intervals between LEVITRA intake and the start of intercourseTimeframe: After 6 months
- Reporting a second successful intercourse within 24 hours of dosingTimeframe: After 6 months
- Patients prefer LEVITRA over last Erectile Dysfunction treatmentTimeframe: After 6 months
- Tolerability of patients with LEVITRA treatmentTimeframe: After 6 months
Additional Information
Copyright © Bayer
Powered by
